Abstract
In some cases of Cushing’s syndrome both bromocriptine and lisuride inhibit the secretion of ACTH but it is still unknown if they act at pituitary or at higher levels. In order to evaluate this aspect, we set up an in vitro perfusion system with anterior pituitary cells from rats and from human ACTH-secreting tumors. In both preparations lysine-vasopressin (LVP) and epinephrine (EPI) stimulated ACTH secretion; prazosin (alpha-1 blocker) inhibited the EPI but not the LVP-mediated stimulation. Similarly, the infusion of lisuride blocked ACTH response to EPI but not to LVP. These data may suggest that “dopaminergic” drugs could act by an adrenergic blockade and not necessarily by a dopaminergic inhibition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Müller O.A., Fahlbusch R., Horowski R. Effect of lisuride on ACTH levels in patients with active Cushing’s disease. Acta Endocrinol. 99: (Suppl.) 246:103,1982.
Boscaro M., Benato M., Mantero F. Effect of bromocriptine in pituitary-dependent Cushing’s syndrome. Clin. Endocrinol. 19: 485,1983.
Boscaro M., Merola G., Serafini E., Mantero F. Effect of short and long-term administrationof lisuride in Cushing’s syndrome. J. Endocrinol. Invest. 8:13,1985.
Lamberts S.W.J., Klijm J.G.M., De Quijada M., Timmermans H.A.T., Uitterlinden P., De Jong F.H., Birkenhäger J.C. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing’s disease and Nelson’s syndrome. J. Clin. Endocrinol. Metab. 51: 307,1980.
Vermes I., Mulder G.H., Smelik P.G. Opposite effetcs of K+-induced depolarization on endorphin/lipotropin secretions by anterior and intermediate, lobes on the rat pituitary. Eur. J. Pharmacol. 63: 89, 1980.
Fisher J.L, Moriarty C.M. Control of bioactive corticotrophin release from neuro-intermediate lobe of the rat pituitary in vitro. Endocrinology 100:1047,1977.
Smelik P.G., Tilders F.J.H. Differential control of anterior lobe and intermediate corticotropin secretion in rat. In: Jones M.T., Gillham B., Dallman M.F., Chattopadhay S. (Eds.), Interaction with brain pituitary pituitary adrenocortical system. Academic Press. London, 1979, p. 29.
Van Loon G.R., Krogt C.L Effect of dopamine on the biological activity and in vitro release of ACTH and FSH. Proc. Soc. Exp. Biol. Med. 133:1137, 1970.
Adams E.F., Ashby M.J., Brown S.M., White M.C., Mashiter K. Bromocriptine suppresses ACTH secretion from human pituitary tumour cells in culture by a dopaminergic mechanism. Clin. Endocrinol. 15: 479,1981.
Lamberts S.W.J., DeLange S.A., Stefanko S.Z. Adrenocorticotropin-secfeting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing’s disease: differences in the regulation of hormone secretion. J. Clin. Endocrinol. Metab. 54: 286,1982.
Giguère V., Còté J., Labrie F. Characteristics of the alpha-adrenergic stimulation ot adrenocorticotropin secretion in rat anterior pituitary cells. Endocrinology 109: 759,1981.
Yeo T., Thorner M.O., Jones A., Lowry P.J., Besser G.M. The effect of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells. Clin. Endocrinol. 10:123,1979.
Ganong W.F. Neurotransmitters involved in ACTH secretion: catecholamines. In: Krieger D.T., Ganong W.F. (Eds.), ACTH and related peptides: structure, regulation and action. Ann. NY Acad. Sci. 297: 509,1977.
Rees L., Butler P.W., Gosling C., Besser G.M. Adrenergic blockade and the corticosteroid and growth hormone response to methyl-amphetamine. Nature 228: 565,1970.
Nakai Y., Imura H., Yoshimi T., Matsukura S. Adrenergic control mechanism for ACTH secretion in man. Acta Endocrinol. (Kbh.) 74: 263,1980.
Raymond V., Lépine J., Giguère V., Lissitzky J.C., Còté J., Labrie F. Parallel stimulation of ACTH, β-LPH, β-endorphin and alpha-MSH release by alpha-adrenergic agents in rat anterior pituitary cells in culture. Mol. Cell. Endocrinol. 22: 295,1981.
Giguère V., Coté J., Labrie F. Specific inhibition by glucocorticoids of the alpha-1 adrenergic stimulation of adrenocorticotropin release in rat anterior pituitary cells. Endocrinology 110:1225,1982.
Giguère V., Labrie F. Additive effects of epinephrine and corticotropin-releas-ing-factor (CRF) on adrenocorticotrophin release in the anterior pituitary cells. Biochem. Biophys. Res. Commun. 110: 456,1983.
Proulx L., Giguère V., Còté J., Labrie F. Multiple factors involved in the control of ACTH secretion. J. Endocrinol. Invest. 7: 257,1984.
Vermes I., Telegdy G., Lissak K. Correlation between hypothalamic serotonin content and adrenal function during acute stress: effect of adrenal corticosteroids on hypothalamic serotonin content. Acta Physiol. Acad. Sci. Hung. 43: 33,1973.
Palkovitz M., Brownstein M., Kizer S.J. Effect of total hypothalamic deafferentation on releasing hormone and neurotransmitter concentrations on the mediobasal hypothalamus in the rat. In: Endroczi E., (Ed.), Int. symp. on cellular and molecular basis of neuroendocrine processes. Hungary Akademini, Krado, Budapest, 1976, p. 575.
Saavedra J.M., Brownstein M., Palkowitz M., Kizr J.S. Axelrod J. Tyrosine-hydroxylase and dopamine-/3-hydroxylase: distribution in the individual rat hypothalamic nuclei. J. Neurochem. 23: 869,1974.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boscaro, M., Menegus, A.M. & Mantero, F. Alpha-1 adrenergic blockade: a possible mechanism of action of dopaminergic drugs on ACTH secretion. J Endocrinol Invest 8, 523–526 (1985). https://doi.org/10.1007/BF03348553
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348553